Schedule 13G ownership disclosure

Tyra Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 90240B106

Event date: 2025-02-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP I, LLC

    Shares: 2,898,103 · Class: 5.7%

  • TCG Crossover Fund I, L.P.

    Shares: 2,898,103 · Class: 5.7%

  • Chen Yu

    Shares: 2,898,103 · Class: 5.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-034972
Form type
SCHEDULE 13G
Filer
TCG Crossover GP I, LLC
CIK
CIK 1839947
Filed
Mar 06, 2025
Reporting period
Feb 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub